Literature DB >> 3756494

The distribution of adrenergic receptors in cerebral blood vessels: an autoradiographic study.

K Nakai, T Itakura, Y Naka, K Nakakita, I Kamei, H Imai, H Yokote, N Komai.   

Abstract

The first morphological evidence of the existence of adrenergic receptors (alpha 1, alpha 2 and beta) within the vascular walls of the central nervous system were presented using the in vitro receptor autoradiographic technique. In the rat pial arteries all three types of adrenergic receptors were demonstrated, whereas the human pial arteries failed to show significant autoradiographic grains of alpha 1 type of adrenergic receptors indicating a considerable inter-species difference in the distribution of adrenergic receptors. alpha 2 and beta receptors in human pial arteries were found not only in the arterial smooth muscle layers but also in the endothelial layers. This suggests a possibility that circulating sympathomimetic agents play some role in controlling the tone or permeability of vascular walls within the central nervous system. A distinct distribution of alpha 1 receptors in cortical layer IV where the vascular plexus was richest may suggest a relation of alpha 1 receptors and blood flow of brain parenchyma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756494     DOI: 10.1016/0006-8993(86)90703-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium.

Authors:  F Bacic; R M McCarron; S Uematsu; M Spatz
Journal:  Metab Brain Dis       Date:  1992-09       Impact factor: 3.584

2.  Direct demonstration of beta1- and evidence against beta2- and beta3-adrenoceptors, in smooth muscle cells of rat small mesenteric arteries.

Authors:  Ana M Briones; Craig J Daly; Francesc Jimenez-Altayo; Sonia Martinez-Revelles; Jose M Gonzalez; John C McGrath; Elisabet Vila
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

3.  Adrenergic, serotoninergic, histaminergic, and imipramine binding sites in post-mortal human cerebral microvessel preparations.

Authors:  C O'Neill; C J Fowler; J O Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants.

Authors:  Z Weintraub; M Solovechick; B Reichman; A Rotschild; D Waisman; O Davkin; A Lusky; Y Bental
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-07       Impact factor: 5.747

5.  Effects of the α₂-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex.

Authors:  Mitsuhiro Fukuda; Alberto L Vazquez; Xiaopeng Zong; Seong-Gi Kim
Journal:  Eur J Neurosci       Date:  2012-10-29       Impact factor: 3.386

Review 6.  Alterations in autonomic cerebrovascular control after spinal cord injury.

Authors:  Dong-Il Kim; Can Ozan Tan
Journal:  Auton Neurosci       Date:  2017-04-04       Impact factor: 3.145

7.  Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review.

Authors:  Mendel Castle-Kirszbaum; Leon Lai; Julian Maingard; Hamed Asadi; R Andrew Danks; Tony Goldschlager; Ronil V Chandra
Journal:  Neurosurg Rev       Date:  2021-03-08       Impact factor: 3.042

8.  Physiopathology of shock.

Authors:  Fabrizio Giuseppe Bonanno
Journal:  J Emerg Trauma Shock       Date:  2011-04

9.  Hemorrhagic shock: The "physiology approach".

Authors:  Fabrizio Giuseppe Bonanno
Journal:  J Emerg Trauma Shock       Date:  2012-10

10.  Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy.

Authors:  Christopher L Moore; David S Henry; Samantha J McClenahan; Kelly K Ball; Nancy J Rusch; Sung W Rhee
Journal:  J Pharmacol Exp Ther       Date:  2020-10-25       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.